SPOP and prostate carcinoma: SPOP knockdown in various prostate cancer cell lines (e.g., C4-2b cells, PC3 cells, LNCap cells, 22Rv1 cells) or U2OS cells reduced the mRNA and protein expression of ATR, BRCA2, ChK1, and Rad51 [35].